XML 20 R17.htm IDEA: XBRL DOCUMENT
v3.20.2

Stock-Based Compensation | 9 Months Ended
--- | ---
Aug. 28, 2020
Share-based Payment Arrangement [Abstract] |
STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION Restricted Stock Units Restricted stock unit activity for the nine months ended August 28, 2020 was as follows:
| Number of Shares (in millions) |  | Weighted Average Grant Date Fair Value |  | Aggregate Fair Value(1) (in millions)
Beginning outstanding balance | 8.6 |  |  | $ | 211.95 |  |  |
Awarded | 3.0 |  |  | $ | 352.14 |  |  |
Released | (3.7) |  |  | $ | 187.73 |  |  |
Forfeited | (0.5) |  |  | $ | 251.12 |  |  |
Ending outstanding balance | 7.4 |  |  | $ | 277.60 |  |  | $ | 3,842 |
Expected to vest | 6.8 |  |  | $ | 275.62 |  |  | $ | 3,510 |
_________________________________________ (1) The aggregate fair value is calculated using the closing stock price as of August 28, 2020 of $516.44. The total fair value of restricted stock units vested during the nine months ended August 28, 2020 was $1.35 billion. Performance Shares In the first quarter of fiscal 2020, the Executive Compensation Committee approved the 2020 Performance Share Program, the terms of which are similar to prior year programs that are still outstanding. For information regarding our Performance Share Programs including the terms, see “Note 12. Stock-Based Compensation” of our Annual Report on Form 10-K for the fiscal year ended November 29, 2019. As of August 28, 2020, the shares awarded under our 2020, 2019 and 2018 Performance Share Programs remain outstanding and are yet to be achieved. Performance share activity for the nine months ended August 28, 2020 was as follows:
| Number of Shares (in millions) |  | Weighted Average Grant Date Fair Value |  | Aggregate Fair Value(1) (in millions)
Beginning outstanding balance | 1.0 |  |  | $ | 199.78 |  |  |
Awarded | 0.6 |  |  | $ | 271.62 |  |  |
Achieved | (0.8) |  |  | $ | 118.84 |  |  |
Forfeited | (0.1) |  |  | $ | 302.12 |  |  |
Ending outstanding balance | 0.7 |  |  | $ | 328.04 |  |  | $ | 372 |
Expected to vest | 0.7 |  |  | $ | 321.11 |  |  | $ | 336 |
_________________________________________ (1) The aggregate fair value is calculated using the closing stock price as of August 28, 2020 of $516.44. Under our Performance Share Programs, participants generally have the ability to receive up to 200% of the target number of shares originally granted. Shares awarded during the nine months ended August 28, 2020 include 0.4 million additional shares awarded for the final achievement of the 2017 Performance Share Program which was certified in the first quarter of fiscal 2020. The remaining awarded shares were for the 2020 Performance Share Program. Shares achieved during the nine months ended August 28, 2020 resulted from 200% achievement of target for the 2017 Performance Share Program. The total fair value of performance shares achieved during the nine months ended August 28, 2020 was $264 million. Employee Stock Purchase Plan Prior to April 2020, shares of common stock purchased by eligible employees through our employee stock purchase plans were issued under our 1997 Employee Stock Purchase Plan (“1997 ESPP”). In April 2020, our stockholders approved the 2020 Employee Stock Purchase Plan (“2020 ESPP”) which amended and restated the 1997 ESPP to increase the maximum number of shares of our common stock that may be issued under the plan. As of August 28, 2020, we had reserved 103.0 million shares of our common stock for issuance under the 2020 ESPP and approximately 12.6 million shares remain available for future issuance. The assumptions used to value employee stock purchase rights during the nine months ended August 28, 2020 and August 30, 2019 were as follows:
| Three Months |  |  |  | Nine Months |  |
| 2020 |  | 2019 |  | 2020 |  | 2019
Expected life (in years) | 0.5 - 2.0 |  | 0.5 - 2.0 |  | 0.5 - 2.0 |  | 0.5 - 2.0
Volatility | 36% - 46% |  | 30% |  | 24% - 46% |  | 30% - 35%
Risk free interest rate | 0.16% - 0.17% |  | 1.78% |  | 0.16% - 1.58% |  | 1.78% - 2.47%
Employees purchased 1.2 million shares at an average price of $218.37 and 1.5 million shares at an average price of $150.55 for the nine months ended August 28, 2020 and August 30, 2019, respectively. The intrinsic value of shares purchased during the nine months ended August 28, 2020 and August 30, 2019 was $216 million and $179 million, respectively. The intrinsic value is calculated as the difference between the market value on the date of purchase and the purchase price of the shares. Compensation Costs As of August 28, 2020, there was $1.73 billion of unrecognized compensation cost, adjusted for estimated forfeitures, related to non-vested stock-based awards and purchase rights which will be recognized over a weighted average period of 2.2 years. Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. Total stock-based compensation costs included in our condensed consolidated statements of income for the three months ended August 28, 2020 and August 30, 2019 were as follows:
(in millions) |  | 2020 |  |  |  | 2019 |  |
Income Statement Classifications |  | Restricted Stock Units and Performance Share Awards |  | Stock Purchase Rights and Options |  | Restricted Stock Units and Performance Share Awards |  | Stock Purchase Rights and Options
Cost of revenue |  | $ | 11 |  |  | $ | 3 |  |  | $ | 10 |  |  | $ | 3 |
Research and development |  | 111 |  |  | 10 |  |  | 84 |  |  | 10 |
Sales and marketing |  | 53 |  |  | 12 |  |  | 48 |  |  | 13 |
General and administrative |  | 29 |  |  | 3 |  |  | 25 |  |  | 3 |
Total |  | $ | 204 |  |  | $ | 28 |  |  | $ | 167 |  |  | $ | 29 |
Total stock-based compensation costs included in our condensed consolidated statements of income for the nine months ended August 28, 2020 and August 30, 2019 were as follows:
(in millions) |  | 2020 |  |  |  | 2019 |  |
Income Statement Classifications |  | Restricted Stock Units and Performance Share Awards |  | Stock Purchase Rights and Options |  | Restricted Stock Units and Performance Share Awards |  | Stock Purchase Rights and Options
Cost of revenue |  | $ | 37 |  |  | $ | 9 |  |  | $ | 30 |  |  | $ | 10 |
Research and development |  | 319 |  |  | 28 |  |  | 245 |  |  | 28 |
Sales and marketing |  | 166 |  |  | 29 |  |  | 159 |  |  | 33 |
General and administrative |  | 81 |  |  | 7 |  |  | 72 |  |  | 8 |
Total |  | $ | 603 |  |  | $ | 73 |  |  | $ | 506 |  |  | $ | 79 |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration